Compare Medpace Holdings Inc (MEDP) vs TotalEnergies SE (TTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs TotalEnergies SE — how do they compare? Medpace Holdings Inc trades at $530.32 (market cap $15.08B), while TotalEnergies SE trades at $82.89 (market cap $179.99B). The key difference: TotalEnergies SE is far larger — about 11.9× Medpace Holdings Inc's market cap, and TotalEnergies SE pays a 5.22% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | TTE | |
|---|---|---|
Market Cap | $15.08B | $179.99B |
Sector | Technology | Energy |
52-Week High | $620.59 | $93.60 |
52-Week Low | $308.88 | $57.39 |
Enterprise Value | $14.55B | $214.14B |
Dividend Yield | — | 5.22% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
TotalEnergies (TTE) trades at $81.23, down 0.2% on the day, with a bullish technical signal supported by moving averages. The company reported a Q1 2026 EPS beat of $2.45 versus $2.22 expected, though revenue has declined from $263.3B in 2022 to $182.3B in 2025. Valuation remains attractive with a P/E of 12.08 and P/S of 0.97. Recent news highlights strategic divestments in solar and new LNG shipments to Asia, reflecting a focus on profitable growth areas.
The outlook is positive with a consensus price target of $100, implying 23% upside, supported by 57.6% analyst buy ratings. Risks include ongoing revenue pressure, geopolitical exposure in the Middle East, and regulatory climate mandates. Cash flow stability and shareholder returns via dividends provide a cushion, but execution on production growth and cost management is critical for sustained appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About TotalEnergies SE
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →
